Patents by Inventor Jun Sub PARK

Jun Sub PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240120584
    Abstract: A secondary battery includes: a can having an accommodation space therein; an electrode assembly accommodated in the accommodation space in the can; and a cap assembly sealed with the can. The can has a beading part recessed into a side wall of the can at a region below where the cap assembly is accommodated, and the beading part has an acute angle with respect to the side wall of the can.
    Type: Application
    Filed: October 11, 2023
    Publication date: April 11, 2024
    Inventors: Jun Ho YANG, Woo Hyuk CHOI, Tae Yoon LEE, Jun Hwan KWON, Joung Ku KIM, Hyun Suk PARK, Dong Sub LEE
  • Publication number: 20240009317
    Abstract: The present invention relates to a long-acting conjugate of an interleukin-2 analog with altered binding affinity for interleukin-2 receptors.
    Type: Application
    Filed: March 31, 2022
    Publication date: January 11, 2024
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Yong Ho HEO, Euh Lim OH, Da Hyeon PARK, Jin Young KIM, Jun Sub PARK, Yu Yon KIM, A Ram LEE, Sang Yun KIM
  • Publication number: 20230348550
    Abstract: Modifications to interleukin-2 alpha receptors are disclosed. Interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors are disclosed.
    Type: Application
    Filed: July 10, 2023
    Publication date: November 2, 2023
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Euh Lim OH, Sang Yun KIM, Yong Ho HEO, Jin Young KIM, Cho Rong PARK, Jun Sub PARK, Hyun Soo RYU
  • Patent number: 11746137
    Abstract: The present invention relates to changes in interleukin-2 alpha receptors and interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: September 5, 2023
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Euh Lim Oh, Sang Yun Kim, Yong Ho Heo, Jin Young Kim, Cho Rong Park, Jun Sub Park, Hyun Soo Ryu
  • Publication number: 20230124171
    Abstract: The present invention relates to changes in interleukin-2 alpha receptors and interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors.
    Type: Application
    Filed: March 31, 2021
    Publication date: April 20, 2023
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Euh Lim OH, Sang Yun KIM, Yong Ho HEO, Jin Young KIM, Cho Rong PARK, Jun Sub PARK, Hyun Soo RYU